TMCI (TMCI) Stock Price & Analysis
TMCI (TMCI) rose 0.00% to USD 4 as of July 25, 2026 at 02:22 UTC, according to Nexqual real-time market data.
TMCI last closed at USD 4; the session ranged USD 3.93–4.1 on volume of 242,329 shares. Market capitalization is —, with a 52-week range of USD 1.17–7.78 (NMS). Source: Nexqual, July 25, 2026 at 02:22 UTC.
Key Statistics (as of July 25, 2026 at 02:22 UTC)
| Price | USD 4 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 4 |
| Open | USD 4 |
| Day Range | USD 3.93 – 4.1 |
| 52-Week Range | USD 1.17 – 7.78 |
| Volume | 242,329 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (TMCI)
Nexqual's technical model rates TMCI "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 02:22 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 47.81 (neutral) |
| vs SMA50 | Above (USD 3.81) |
| MACD | 0.07 (positive) |
From TMCI's Latest SEC 10-K Filing (filed 2026-02-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SGHT | Sight Sciences, Inc. | USD 4.91 | ▼ 2.39% |
| CTKB | Cytek Biosciences, Inc. | USD 4.46 | ▼ 1.76% |
| DSGN | Design Therapeutics, Inc. | USD 11.78 | ▲ 0% |
| LUNG | Pulmonx Corporation | USD 1.17 | ▼ 3.31% |
| CVRX | CVRx, Inc. | USD 4.74 | ▼ 6.88% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:22 UTC. This page is informational and not investment advice.